Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 26 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
251 23.6 months HER2-positive metastatic breast cancer 4 Biologic therapy
Chemotherapy
Jules Bordet Institute Belgium 12/2013
Treatment Details: Patients: This phase 2 study involved female, previously treated, HER2+, locally advanced/metastatic breast cancer patients who were divided into two separate treatment groups. Group A ha
 
252 23.5 months Chronic lymphocytic leukemia 5 Biologic therapy
Hormone
University of Liverpool United Kingdom 5/2012
Treatment Details: Patients: This study involved 39 chronic lymphocytic leukemia patients who had a genetic deletion of the TP53 gene. The median patient age was 62 years and 56% were male. Treatment: Pa
 
253 23.5 months Metastatic colorectal cancer 4 Chemotherapy
Istituto Nazionale Tumor Italy 11/2007
Treatment Details: Patients: This phase I/II study involved 38 patients with metastatic colorectal cancer. Their median age was 60, ranging from 35-73 years old. The majority (26) were men. Sixty-six perce
 
254 23.4 months metastatic breast cancer 4 Chemotherapy
Humboldt University Berlin Germany 1/2005
Treatment Details: Patients: This Phase III study involved 93 women with metastatic breast cancer. The patients were randomly placed into two groups: Group A had 48 patients (median age 48.9 years). All patie
 
255 23.2 months Metastatic colorecal cancer 3 Biologic therapy
Chemotherapy
Prosper Hospital Recklinghausen Germany 9/2013
Treatment Details: Patients: This phase 2 study involved 49 metastatic colorectal cancer patients who had not been previously treated. The median patient age was 63.4 years and 76% were male. Treatment:
 
256 23.1 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Dana-Farber Cancer Institute United States 10/2007
Treatment Details: Patients: This phase III study involved 430 patients with previously untreated metastatic colorectal cancer. These patients ranged in age from 20 to 87 years old. Treatment: Patients w
 
257 23.0 months MPM 5 Chemotherapy
Surgery
University Hospital Zurich Switzerland 4/2007
Treatment Details: Patients: This study enrolled 61 patients (57 men and 4 women) with malignant pleural mesothelioma. The median age was 59 years, ranging from 44-72. Treatment: Fifty-eight patients c
 
258 23.0 months Malignant pleural mesothelioma 3 Biologic therapy
Surgery
New York University School of Medicine United States 8/2008
Treatment Details: Patients: This phase II study involved 30 patients with malignant pleural mesothelioma. The average age was 66, ranging from 49 to 84 years of age. There were 25 men and 5 women. Trea
 
259 23.0 months Ovarian cancer 4 Chemotherapy
Instituto Valenciano de Oncologıa Spain 1/2011
Treatment Details: Patients: This study involved ovarian cancer patients with partially platinum-sensitive relapse after previous platinum-based therapy. Patients were divided into two separate treatment gro
 
260 23.0 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Institut Gustave Roussy France 4/2013
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were separated into two different treatment groups. Group A consisted of 72 patients with a median age of 61
 
Page 26 of 187  | Previous Page  | Next Page